Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Free Cash Flow (2021 - 2025)

Historic Free Cash Flow for P3 Health Partners (PIII) over the last 5 years, with Q3 2025 value amounting to -$15.4 million.

  • P3 Health Partners' Free Cash Flow rose 3185.96% to -$15.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$122.7 million, marking a year-over-year decrease of 7904.92%. This contributed to the annual value of -$110.1 million for FY2024, which is 4145.27% down from last year.
  • Per P3 Health Partners' latest filing, its Free Cash Flow stood at -$15.4 million for Q3 2025, which was up 3185.96% from -$16.6 million recorded in Q2 2025.
  • P3 Health Partners' 5-year Free Cash Flow high stood at -$6.8 million for Q3 2021, and its period low was -$57.2 million during Q4 2024.
  • Over the past 5 years, P3 Health Partners' median Free Cash Flow value was -$21.9 million (recorded in 2022), while the average stood at -$23.0 million.
  • Within the past 5 years, the most significant YoY rise in P3 Health Partners' Free Cash Flow was 6589.41% (2024), while the steepest drop was 26536.45% (2024).
  • Over the past 5 years, P3 Health Partners' Free Cash Flow (Quarter) stood at -$11.6 million in 2021, then tumbled by 175.0% to -$31.9 million in 2022, then soared by 50.9% to -$15.7 million in 2023, then crashed by 265.36% to -$57.2 million in 2024, then skyrocketed by 73.07% to -$15.4 million in 2025.
  • Its Free Cash Flow was -$15.4 million in Q3 2025, compared to -$16.6 million in Q2 2025 and -$33.5 million in Q1 2025.